280 related articles for article (PubMed ID: 30977390)
1. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
Mehrotra DV
Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
[TBL] [Abstract][Full Text] [Related]
2. Seeking harmony: estimands and sensitivity analyses for confirmatory clinical trials.
Mehrotra DV; Hemmings RJ; Russek-Cohen E;
Clin Trials; 2016 Aug; 13(4):456-8. PubMed ID: 26908545
[TBL] [Abstract][Full Text] [Related]
3. Incorporating estimands into clinical trial statistical analysis plans.
Kang M; Kendall MA; Ribaudo H; Tierney C; Zheng L; Smeaton L; Lindsey JC
Clin Trials; 2022 Jun; 19(3):285-291. PubMed ID: 35257600
[TBL] [Abstract][Full Text] [Related]
4. A constructive critique of the
Scharfstein DO
Clin Trials; 2019 Aug; 16(4):375-380. PubMed ID: 31184495
[TBL] [Abstract][Full Text] [Related]
5. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
Phillips A; Clark T
Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
[TBL] [Abstract][Full Text] [Related]
6. Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
Morga A; Latimer NR; Scott M; Hawkins N; Schlichting M; Wang J
Value Health; 2023 Feb; 26(2):234-242. PubMed ID: 36150999
[TBL] [Abstract][Full Text] [Related]
7. Application of the Estimand Framework to Anesthesia Trials.
De Silva AP; Leslie K; Braat S; Grobler AC
Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
[TBL] [Abstract][Full Text] [Related]
8. A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?
Mitroiu M; Oude Rengerink K; Teerenstra S; Pétavy F; Roes KCB
Trials; 2020 Jul; 21(1):671. PubMed ID: 32703247
[TBL] [Abstract][Full Text] [Related]
9. Defining treatment effects: A regulatory perspective.
Permutt T
Clin Trials; 2019 Aug; 16(4):345-349. PubMed ID: 30764658
[TBL] [Abstract][Full Text] [Related]
10. Estimands in hematologic oncology trials.
Sun S; Weber HJ; Butler E; Rufibach K; Roychoudhury S
Pharm Stat; 2021 Jul; 20(4):793-805. PubMed ID: 33686762
[TBL] [Abstract][Full Text] [Related]
11. Estimands: discussion points from the PSI estimands and sensitivity expert group.
Phillips A; Abellan-Andres J; Soren A; Bretz F; Fletcher C; France L; Garrett A; Harris R; Kjaer M; Keene O; Morgan D; O'Kelly M; Roger J
Pharm Stat; 2017 Jan; 16(1):6-11. PubMed ID: 26997517
[TBL] [Abstract][Full Text] [Related]
12. Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PPJ
Trials; 2024 Mar; 25(1):180. PubMed ID: 38468320
[TBL] [Abstract][Full Text] [Related]
13. Understanding estimands.
Gogtay NJ; Ranganathan P; Aggarwal R
Perspect Clin Res; 2021; 12(2):106-112. PubMed ID: 34012908
[TBL] [Abstract][Full Text] [Related]
14. Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyond.
Rufibach K
Pharm Stat; 2019 Mar; 18(2):145-165. PubMed ID: 30478869
[TBL] [Abstract][Full Text] [Related]
15. Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice.
Mallinckrodt CH; Bell J; Liu G; Ratitch B; O'Kelly M; Lipkovich I; Singh P; Xu L; Molenberghs G
Ther Innov Regul Sci; 2020 Mar; 54(2):353-364. PubMed ID: 32072593
[TBL] [Abstract][Full Text] [Related]
16. Connecting Instrumental Variable methods for causal inference to the Estimand Framework.
Bowden J; Bornkamp B; Glimm E; Bretz F
Stat Med; 2021 Nov; 40(25):5605-5627. PubMed ID: 34288021
[TBL] [Abstract][Full Text] [Related]
17. Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.
Yassi N; Hayward KS; Campbell BCV; Churilov L
Stroke; 2021 Nov; 52(11):3739-3747. PubMed ID: 34587797
[TBL] [Abstract][Full Text] [Related]
18. Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.
Ratitch B; Bell J; Mallinckrodt C; Bartlett JW; Goel N; Molenberghs G; O'Kelly M; Singh P; Lipkovich I
Ther Innov Regul Sci; 2020 Mar; 54(2):324-341. PubMed ID: 32072573
[TBL] [Abstract][Full Text] [Related]
19. Estimands in clinical trials - broadening the perspective.
Akacha M; Bretz F; Ruberg S
Stat Med; 2017 Jan; 36(1):5-19. PubMed ID: 27435045
[TBL] [Abstract][Full Text] [Related]
20. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials.
Qu Y; Shurzinske L; Sethuraman S
Pharm Stat; 2021 Mar; 20(2):314-323. PubMed ID: 33098267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
